2-Chloro-5-Iodobenzoic Acid CAS 19094-56-5 Empagliflozin Intermediate Assay ≥99.0% (HPLC)

Nkọwa dị mkpirikpi:

Aha Chemical: 2-Chloro-5-Iodobenzoic Acid

OZI: 19094-56-5

Nyocha: ≥99.0% (HPLC)

Ọdịdị: kristal na-acha ọcha ma ọ bụ na-acha odo odo

Ọkara nke Empagliflozin (CAS: 864070-44-0) maka ọgwụgwọ ụdị ọrịa shuga 2.

Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Onye na-emepụta ihe, ịdị ọcha dị elu, mmepụta azụmahịa
Aha Chemical: 2-Chloro-5-Iodobenzoic Acid
OZI: 19094-56-5

Njirimara kemịkalụ:

Aha Chemical	2-Chloro-5-Iodobenzoic acid
Nọmba CAS	19094-56-5
Nọmba CAT	RF-PI438
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C7H4ClIO2
Ibu molekụla	282.46
Solubility	Soluble na methanol
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	kristal na-acha ọcha ma ọ bụ na-acha odo odo
Usoro nyocha / nyocha	≥99.0% (HPLC)
Ebe Na-agbaze	161.0 ~ 163.0 ℃
Ọnwụ na ihicha	≤0.50%
Ihe fọdụrụ na mgbanye	≤0.20%
Mgbakọta adịghị ọcha	≤1.0%
Ọla dị arọ	≤20ppm
Ihe mgbaze fọdụrụnụ	Ethanol
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ọkara nke Empagliflozin (CAS: 864070-44-0)

2-Chloro-5-Iodobenzoic Acid (CAS 19094-56-5) Ụzọ sịntetik

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri.

Uru:

Ajụjụ:

Ngwa:

Enwere ike iji 2-Chloro-5-Iodobenzoic Acid (CAS: 19094-56-5) dị ka onye na-ahụ maka ọgwụ na njikọ nke Empagliflozin (CAS: 864070-44-0).Empagliflozin (aha ahia Jardiance) bụ onye na-egbochi sodium glucose co-transporter-2 (SGLT-2), na-eme ka akụrụ wepụta shuga dị n'ọbara wee wepụ ya na mmamịrị.Na August 1, 2014, nri na ọgwụ nchịkwa (FDA) kwadoro ọgwụ ahụ maka ọgwụgwọ ụdị ọrịa shuga 2, iji melite na ịchịkwa glucose ọbara nke ndị okenye.Empagliflozin bụ ọgwụ SGLT-2 nke atọ na-egbochi ọgwụ FDA kwadoro.Ọgwụ abụọ SGLT-2 inhibitor, Canagliflozin na Dapagliflozin, nke Johnson Pharmaceuticals, AstraZeneca na Bristol-Myers Squibb n'otu n'otu, bụ ndị FDA kwadoro na Nọvemba 2013 na Jenụwarị 2014 n'otu n'otu.